Shares of Doximity surged by more than 100 percent in overnight trading this Friday. The rapid increase followed a strong fiscal first-quarter report and updated revenue guidance from the digital medical platform.
CEO Jeffrey Tangney highlighted the performance of the company's new AI search tool during the earnings call on Thursday. Tangney reported that the tool generates revenue 10 times higher than its operating cost. He expects these unit economics to improve further as AI models become more efficient over time. This commentary sparked significant market interest, as investors reacted to the potential for long-term margin expansion.
Analysts noted that the company’s recent upward revision to its annual revenue guidance did not fully account for these AI-driven earnings. Experts suggest that management took a conservative stance on the forecast, leaving room for future outperformance. Beyond the product updates, the stock experienced additional upward pressure from a short squeeze. With approximately 17 percent of available shares sold short prior to the announcement, the scramble by short sellers to close positions contributed to the extreme price movement.
While the stock settled slightly lower after the market officially opened, the activity underscores a shift in how investors view Doximity's growth trajectory. The company now eyes a larger addressable market within the pharmaceutical and health sectors as its technology matures. The market remains focused on whether these gains can hold as the fiscal year progresses.